The drug ABATIXENT contains
one active pharmaceutical ingredient (API):
This drug has been classified in the anatomical therapeutic chemical (ATC) classification
system as follows:
This drug has been assigned below unique identifiers within the countries it is being marketed:
EC
Agencia Nacional de Regulación, Control y Vigilancia Sanitaria
Identifier(s):
7670-MEE-1222, 7671-MEE-1222
EE
Ravimiamet
Identifier(s):
1804722, 1804733, 1804744, 1804755, 1804766, 1804777, 1804788, 1804799, 1804801, 1804812, 1804823, 1804834, 1804845, 1804856, 1804867, 1804878, 1804889, 1804890, 1804902, 1804913, 1804924, 1804935, 1804946, 1804957
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s):
1093513, 1093514, 1093515, 1093516, 1093517, 1093518, 1093519, 1093520, 1093521, 1093522, 1093523, 1093524, 1093525, 1093526, 1093527, 1093528, 1093529, 1093530, 1093531, 1093532, 1093533, 1093534, 1093535, 1093536, 1093537, 1093538, 1093539, 1093540, 1093541, 1093542, 1093543, 1093544
PL
Rejestru Produktów Leczniczych
Identifier(s):
100428090, 100428108
RO
Agenția Națională a Medicamentului și a Dispozitivelor Medicale
Identifier(s):
W68484001, W68484002, W68484003, W68484004, W68484005, W68484006, W68484007, W68484008, W68484009, W68484010, W68484011, W68484012, W68484013, W68484014, W68484015, W68484016, W68485001, W68485002, W68485003, W68485004, W68485005, W68485006, W68485007, W68485008, W68485009, W68485010, W68485011, W68485012, W68485013, W68485014, W68485015, W68485016